Recently, it was suggested that biallelic TP53 lesions are a potent driver of MDS progression, which reinforced the significance of investigation into the TP53 allelic state both for diagnosis, monitoring the disease, and the identification of high-risk MDS cases [10]. Here, TP53 is linked to myelodysplastic syndrome.